These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31672251)

  • 1. Change in Albuminuria and Estimated GFR as End Points for Clinical Trials in Early Stages of CKD: A Perspective From European Regulators.
    Holtkamp F; Gudmundsdottir H; Maciulaitis R; Benda N; Thomson A; Vetter T
    Am J Kidney Dis; 2020 Jan; 75(1):6-8. PubMed ID: 31672251
    [No Abstract]   [Full Text] [Related]  

  • 2. Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.
    Levey AS; Gansevoort RT; Coresh J; Inker LA; Heerspink HL; Grams ME; Greene T; Tighiouart H; Matsushita K; Ballew SH; Sang Y; Vonesh E; Ying J; Manley T; de Zeeuw D; Eckardt KU; Levin A; Perkovic V; Zhang L; Willis K
    Am J Kidney Dis; 2020 Jan; 75(1):84-104. PubMed ID: 31473020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in Estimated GFR and Albuminuria as End Points in Clinical Trials: A Viewpoint From the FDA.
    Thompson A; Smith K; Lawrence J
    Am J Kidney Dis; 2020 Jan; 75(1):4-5. PubMed ID: 31672253
    [No Abstract]   [Full Text] [Related]  

  • 4. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.
    Levey AS; Inker LA; Matsushita K; Greene T; Willis K; Lewis E; de Zeeuw D; Cheung AK; Coresh J
    Am J Kidney Dis; 2014 Dec; 64(6):821-35. PubMed ID: 25441437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in Estimated GFR and Albuminuria as End Points in Clinical Trials: A Perspective of People Living With Kidney Disease.
    Baliker M; Bressler K; Forfang D; Fowler KJ; Grandinetti A
    Am J Kidney Dis; 2020 Jan; 75(1):9-10. PubMed ID: 31672252
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration.
    Inker LA; Grams ME; Guðmundsdóttir H; McEwan P; Friedman R; Thompson A; Weiner DE; Willis K; Heerspink HJL;
    Am J Kidney Dis; 2022 Oct; 80(4):513-526. PubMed ID: 35970679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating glomerular filtration rate (GFR) in diabetes: the performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria.
    Vučić Lovrenčić M; Radišić Biljak V; Božičević S; Prašek M; Pavković P; Knotek M
    Clin Biochem; 2012 Dec; 45(18):1694-6. PubMed ID: 22968085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
    Coresh J; Astor BC; Greene T; Eknoyan G; Levey AS
    Am J Kidney Dis; 2003 Jan; 41(1):1-12. PubMed ID: 12500213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Obesity and Chronic Kidney Disease, Defined by Both Glomerular Filtration Rate and Albuminuria, in Korean Adults.
    Kim YJ; Hwang SD; Oh TJ; Kim KM; Jang HC; Kimm H; Kim HC; Jee SH; Lim S
    Metab Syndr Relat Disord; 2017 Oct; 15(8):416-422. PubMed ID: 28832275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Albuminuria and GFR Among Adolescents in the United States, 1988-2014.
    Saydah SH; Xie H; Imperatore G; Burrows NR; Pavkov ME
    Am J Kidney Dis; 2018 Nov; 72(5):644-652. PubMed ID: 30017204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States.
    Ishigami J; Padula WV; Grams ME; Chang AR; Jaar B; Gansevoort RT; Bridges JFP; Kovesdy CP; Uchida S; Coresh J; Matsushita K
    Am J Kidney Dis; 2019 Jul; 74(1):23-35. PubMed ID: 30898360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Combination of Change in Albuminuria and GFR as a Surrogate End Point for Progression of CKD.
    Coresh J; Levey AS
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):792-794. PubMed ID: 31175080
    [No Abstract]   [Full Text] [Related]  

  • 15. Microcirculatory marker for the prediction of renal end points: a prospective cohort study in patients with chronic kidney disease stage 2 to 4.
    Baumann M; Burkhardt K; Heemann U
    Hypertension; 2014 Aug; 64(2):338-46. PubMed ID: 24866146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation.
    Hilbrands L; Budde K; Bellini MI; Diekmann F; Furian L; Grinyó J; Heemann U; Hesselink DA; Loupy A; Oberbauer R; Pengel L; Reinders M; Schneeberger S; Naesens M
    Transpl Int; 2022; 35():10139. PubMed ID: 35669976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary albumin excretion and chronic kidney disease in children with vesicoureteral reflux.
    de Sépibus R; Cachat F; Meyrat BJ; Dushi G; Boubaker A; Faouzi M; Girardin E; Chehade H
    J Pediatr Urol; 2017 Dec; 13(6):592.e1-592.e7. PubMed ID: 28483464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population.
    Robles NR; Felix FJ; Fernandez-Berges D; Perez-Castán JF; Zaro MJ; Lozano L; Alvarez-Palacios P; Garcia-Trigo A; Tejero V; Morcillo Y; Hidalgo AB
    J Nephrol; 2013; 26(4):675-82. PubMed ID: 23100180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of patients with resistant hypertension and chronic kidney disease.
    Verdalles Ú; Goicoechea M; Garcia de Vinuesa S; Quiroga B; Galan I; Verde E; Perez de Jose A; Luño J
    Nefrologia; 2016; 36(5):523-529. PubMed ID: 27445099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albuminuria during treatment with angiotensin type II receptor blocker is a predictor for GFR decline among non-diabetic hypertensive CKD patients.
    Yu MY; Kim DK; Park JH; Shin SJ; Lee SH; Choi BS; Lim CS; Chin HJ
    PLoS One; 2018; 13(8):e0202676. PubMed ID: 30148871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.